Search
  1. Home
  2. Southern Africa
  3. Botswana

Still no guidelines for generic AIDS drugs

    JOHANNESBURG

    International health officials attending a conference in Botswana had failed to reach an agreement on global guidelines for low-cost generic HIV/AIDS drugs after US officials raised concerns about their safety, the Associated Press news agency reported.

    The World Health Organisation (WHO) said fixed-dose combination drugs containing three medicines in one pill were considerably cheaper than their patented equivalents and a key part of its plan to treat 3 million people in developing countries by 2005.

    However, US officials questioned whether WHO's screening process was stringent enough, and expressed concern that widespread, inappropriate distribution of the drugs could lead to drug resistance.

    Organisers of the Conference on Fixed-Dose Combination Drug Products plan to publish their deliberations for comment by 19 April.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join